QNTM (Quantum BioPharma Ltd) Short-Term Debt to Capital

Corporate company logo of Quantum BioPharma Ltd (QNTM)

Quantum BioPharma Ltd (QNTM) is a small Canadian business undergoing a prolonged strategic shift, which has stripped it of its pricing power in the market. However, expansion potential is embedded in molecule patents that allow for the scaling of drug production via outsourcing. The price action on the chart confirms this, with the debt-to-equity ratio standing at 0.12. The holding company currently relies on external financing, as the development of cannabis-based medicines has yet to generate regular income.

Ratio of Short-Term Indebtedness to Capital: Quantum BioPharma Limited (QNTM) for 08/16/2024 - 10/30/2026

Analytical breakdowns for Quantum BioPharma Ltd

- stock quotes and analyst forecast:
Stock Price Quantum BioPharma Limited|QNTM - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Quantum BioPharma Ltd.|QNTM - Enterprise Value
- book capitalization information:
Net Assets per Single Share Quantum BioPharma|QNTM - Accounting Value of Company|Market Value to Book Value Ratio quantumbiopharma.com|QNTM - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Quantum BioPharma Ltd|QNTM - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Quantum BioPharma|QNTM - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Quantum BioPharma Ltd.|QNTM - Long-Term Debt|Company Current Liabilities Quantum BioPharma|Quick Ratio quantumbiopharma.com
- company profitability and valuation multiples indicators:
QNTM - Final Profit
Fundamental valuation:QNTM Quantum BioPharma Limited
Brand item of Quantum BioPharma Ltd.

This indicator measures the proportion of short-term liabilities within the equity structure, reflecting the company's reliance on rapid debt financing and liquidity risk amid rising rates. Analyzing the ratio of short-term debt to equity on GURU.Markets allows for an assessment of how aggressively Quantum BioPharma Ltd (QNTM) is investing in AI search and neurodrug development by utilizing external credit lines to accelerate expansion.

Competitors of Quantum BioPharma Ltd (QNTM)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|AQST: Short-Term Debt to Capital|scPharmaceuticals - Ratio of Short-Term Indebtedness to Capital|TECX (Tectonic Therapeutic Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Tonix Pharmaceuticals Holding TNXP|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity BioHarvest Sciences Inc. BHST|Short-Term Indebtedness to Equity Invizyne Technologies|ORMP: Short-Term Debt to Equity Ratio|ENTX - Short-Term Debt to Capital|HYFT: Short-Term Debt to Capital|abvcpharma.com (ABVC) - Short-Term Debt to Capital|Short-Term Debt to Equity Cumberland Pharmaceuticals Inc.|Short-Term Debt to Capital Ratio FGEN (FibroGen Inc)|Short-Term Debt to Equity Ratio TELO (Telomir Pharma)|Short-Term Loans to Capital Ratio RANI|Synergy CHC - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Rallybio Corp RLYB|LEXX - Short-Term Debt to Equity|Pulmatrix Inc (PULM) - Short-Term Debt to Equity Ratio|PTHL (ftzy.com.cn) - Short-Term Debt to Equity Ratio|Aptorum Group - Ratio of Short-Term Indebtedness to Capital|LYRA (Lyra Therapeutics, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity IBO|Short-Term Debt to Capital TNFA|Short-Term Debt to Capital Coefficient cbdmd.com|Short-Term Debt to Equity PainReform Limited PRFX|Altamira Therapeutics Ltd (CYTO) - Current Liabilities to Capital|LIPO - Short-Term Debt to Equity|Current Liabilities to Equity OPTN|PIRS: Short-Term Debt to Capital|Procaps Group - Ratio of Short-Term Indebtedness to Capital|PTPI (Petros) - Short-Term Debt to Capital|Short-Term Debt to Capital Qilian International Corp|Short-Term Debt to Equity Acelyrin, Inc. (SLRN)|TFFP (tffpharma.com) - Ratio of Short-Term Indebtedness to Capital